FFRangio System vs CardIQ Suite
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
The FFRangio System offers real-time 3D FFR guidance for optimizing PCI decisions during interventional procedures, focusing on functional assessment from angiograms. Conversely, the CardIQ Suite is an AI-powered cardiac CT post-processing application for diagnostic calcium scoring and CCTA review, primarily for anatomical assessment and treatment planning from CT scans. While both address coronary artery disease, their distinct input modalities and primary use cases make them complementary rather than direct competitors.
Choose FFRangio System if…
Choose the FFRangio System if you require real-time, wire-free physiological guidance during percutaneous coronary intervention (PCI) to optimize and confirm treatment decisions. This tool is ideal for assessing multi-vessel coronary artery disease and evaluating lesion impact without invasive pressure wires or drugs, providing immediate insights to guide stent placement and confirm procedural success.
View FFRangio System →Choose CardIQ Suite if…
Choose CardIQ Suite if your primary need is comprehensive, AI-powered cardiac CT post-processing for diagnostic purposes and treatment planning. This system excels at automated calcium scoring, detailed CCTA review, and plaque quantification, enabling thorough pre-procedural assessment of cardiovascular disease and risk stratification.
View CardIQ Suite →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | FFRangio System | CardIQ Suite |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Unknown |
| Deployment | SaaS, on-prem, hybrid | On-premise (integrated with CT systems) |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | FFRangio System | CardIQ Suite |
|---|---|---|
| Product Name | FFRangio System | CardIQ Suite |
| Company | CathWorks | GE Medical Systems SCS |
| Primary Application | Wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in coronary artery disease | AI-powered cardiac CT post-processing for automated calcium scoring and CCTA review |
| Key Methodology/Guidance | Real-time FFRangio values at every point on the coronary tree; Simulated pullback curve; Lesion Impact feature | Deep Learning based automated Calcium Score and labeling of coronary artery territories; CCTA 2D Review; Plaque ID tool |
| Eliminates Invasive Procedures | Eliminates the need for invasive pressure wires, drugs, or a guide catheter | Not specified |
| Automated Calcium Scoring | Not specified | Deep Learning based automated Calcium Score and labeling of coronary artery territories |
Videos
Demos, reviews, and walkthroughs featuring FFRangio System and CardIQ Suite.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
The FFRangio System integrates directly into the cath lab, providing real-time, wire-free FFR guidance to optimize PCI decisions and assess residual ischemia during interventional procedures. In contrast, CardIQ Suite is an AI-powered post-processing application for cardiac CT scans, primarily aiding in the diagnostic interpretation of calcium scoring and CCTA data for comprehensive cardiovascular disease diagnosis and treatment planning.
FFRangio delivers real-time FFRangio values, simulated pullback curves, and lesion impact assessments to guide interventional decisions in the cath lab, eliminating the need for invasive pressure wires or drugs. CardIQ Suite offers automated calcium scoring, CCTA review with plaque identification, and detailed measurements for comprehensive anatomical and plaque burden assessment, primarily for diagnostic purposes. These tools address different stages of a patient's cardiac care, from initial diagnosis via CT to interventional planning.
The FFRangio System offers seamless integration with cath lab booms and PACS, facilitating the flow of imaging data. While CardIQ Suite provides an integrated workflow for reviewing CT data within its GE Advantage Workstation environment, physicians would need to inquire about specific EHR integration capabilities for automated results reporting beyond its native system.
The FFRangio System features an intuitive user interface and AI assistance for quick angiogram analysis, with studies suggesting a short learning curve for cath lab staff to achieve maximal performance. CardIQ Suite is designed for automation and workflow efficiency in CT post-processing, aiming for rapid proficiency and immediate gains in diagnostic review time due to its deep learning algorithms.
While not explicitly detailed in the provided descriptions, medical devices and post-processing software typically incorporate audit logs to track user interactions, data access, and changes made within the system. Physicians should inquire about the granularity and accessibility of these audit trails to support clinical accountability and regulatory requirements.
Both tools are deployed on-premise, meaning each site would require dedicated hardware and integration with local cath lab equipment for FFRangio or GE Advantage Workstations for CardIQ Suite. Multi-site deployment would involve coordinating hardware installation, network configuration, and staff training across each individual location.